Previous close | 79.50 |
Open | 90.20 |
Bid | 83.00 |
Ask | 92.50 |
Strike | 280.00 |
Expiry date | 2024-06-21 |
Day's range | 90.20 - 90.40 |
Contract range | N/A |
Volume | |
Open interest | 106 |
Biogen (BIIB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
A closer look at one of the leaders in the global multiple sclerosis therapeutics market
The FDA will now hold an advisory committee meeting to discuss Eli Lilly's Alzheimer's drug, donanemab. Is Eli Lilly stock a buy or a sell?